vimarsana.com
Home
Live Updates
2023 SABCS | Laekna Reports Afuresertib Phase Ib Breast Canc
2023 SABCS | Laekna Reports Afuresertib Phase Ib Breast Canc
2023 SABCS | Laekna Reports Afuresertib Phase Ib Breast Cancer Study Results
/PRNewswire/ -- Laekna (2105.HK), a clinical-stage biotechnology company, announced reporting the results of a phase Ib study to evaluate the efficacy and...
Related Keywords
United States ,
Shanghai ,
China ,
Yong Yue ,
Jiangsu ,
Chinese ,
Binghe Xu ,
Prnewswire Laekna ,
World Health Organization ,
Academician Of The Chinese Academy Engineering ,
Laekna Inc ,
International Agency For Research On Cancer ,
Chinese Academy ,
Antonio Breast Cancer Symposium ,
Poster Spotlight Session ,
Chief Medical Officer ,
International Agency ,
Main Board ,
Stock Exchange ,
Hong Kong Limited ,
Kong Stock ,
Englj Med ,
Stat Facts ,
Female Breast Cancer Subtypes ,
Laekna ,